Hackensack Meridian Mountainside Medical Center has been approved to use Pluvicto™, an FDA-approved, targeted radioligand therapy for treatment of metastatic prostate-specific membrane antigen positive castration-resistant prostate cancer (PSMA+ mCRPC). Pluvicto™ is the first, and only targeted radioligand therapy for patients with PSMA+ mCRPC. The approval makes Mountainside Medical Center the first in the state to offer…

Hackensack Meridian Mountainside Medical Group has announced that Elizabeth S. John, M.D., gastroenterologist, has joined the practice. A fellowship trained gastroenterologist, Dr. John is passionate about her specialty. “I have always loved gastroenterology as our digestive system really does affect so much of what we do outside of how we digest our food,” Dr. John shares. “The mind-body-gut axis…

Mountainside Medical Center is excited to honor Anjannette “AJ” Hutchinson, RN, BSN, manager of emergency services, as an exceptional leader. AJ has been a team member at Mountainside since 2002 where she started as an agency nurse and quickly found that Mountainside was where she wanted to develop her career.  Starting as a full-time night…

Mountainside Medical Center is excited to honor Rebecca Light, RN, director of behavioral health services, as an exceptional leader. Rebecca is a transformational leader that is always open to any challenge. She is an expert in the field of behavioral health and a great partner to all of us. She has created an excellent team…

Mountainside Medical Group has announced that Rajeeshree Chinchankar, M.D., OB/GYN, has joined the practice. Dr. Chinchankar, received her medical degree in Obstetrics and Gynecology from Seth GS Medical College & K.E.M Hospital located in Mumbai, India. Following her completion of medical school, she became a research fellow for Obstetrics and Gynecology at the Cleveland Clinic Foundation and completed residency…

The first PET Imaging scan using the prostate-specific antigen (PSA) imaging agent, Illucix® was performed at Mountainside Medical Center on Wednesday, July 30, 2022. According to the American Cancer Society, prostate cancer is the most common cancer in American men, with an estimated 268,490 new cases projected for 2022.  In most cases, conventional screening does not…